Louisiana Gene Therapy Research Consortium Inc New Orleans, LA - 70112

Louisiana Gene Therapy Research Consortium Inc is categorized under Associations in New Orleans, LA and active since 1999.

Louisiana Gene Therapy Research Consortium Inc was established in 1999, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Associations business, which does work in the B2B market, and is classified as a Associations, under code number 813910 by the NAICS.

If you are seeking more information, feel free to contact Steven Moye at the company’s single location by writing to 1700 Tulane Avenue, New Orleans, Louisiana LA 70112 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Louisiana Gene Therapy Research Consortium Inc
Contact Person: Steven Moye
Address: 1700 Tulane Avenue, New Orleans, Louisiana 70112
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Associations
SIC Code: 8611
NAICS Code: 813910
Share This Business:

Louisiana Gene Therapy Research Consortium Inc was started in 1999 to provide professional Associations under the SIC code 8611 and NAICS code 813910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Steven Moye for inquiries that concern Louisiana Gene Therapy Research Consortium Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Louisiana Gene Therapy Research Consortium Inc can be found at the coordinates 29.956917,-90.080172 as well as the street address 1700 Tulane Avenue in New Orleans, Louisiana 70112.

For its online presence, you may visit Louisiana Gene Therapy Research Consortium Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.